BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17097878)

  • 1. Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical intervention.
    Farshid G; Downey P; Gill PG
    Breast; 2007 Apr; 16(2):161-71. PubMed ID: 17097878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucocele-like lesions of the breast: a benign cause for indeterminate or suspicious mammographic microcalcifications.
    Farshid G; Pieterse S; King JM; Robinson J
    Breast J; 2005; 11(1):15-22. PubMed ID: 15647073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of full-field digital mammography on pre-operative diagnosis and surgical treatment of mammographic microcalcification.
    Bundred SM; Zhou J; Whiteside S; Morris J; Wilson M; Hurley E; Bundred N
    Breast Cancer Res Treat; 2014 Jan; 143(2):359-66. PubMed ID: 24318468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of core biopsy for ductal carcinoma in situ and its implications for surgical practice.
    Dillon MF; Quinn CM; McDermott EW; O'Doherty A; O'Higgins N; Hill AD
    J Clin Pathol; 2006 Jul; 59(7):740-3. PubMed ID: 16803949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postexcision mammography is indicated after resection of ductal carcinoma-in-situ of the breast.
    Waddell BE; Stomper PC; DeFazio JL; Hurd TC; Edge SB
    Ann Surg Oncol; 2000 Oct; 7(9):665-8. PubMed ID: 11034243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative excision of wire-bracketed breast carcinomas: a community hospital's experience.
    Florentine BD; Kirsch D; Carroll-Johnson RM; Senofsky G
    Breast J; 2004; 10(5):398-404. PubMed ID: 15327492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.
    Cuncins-Hearn A; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
    ANZ J Surg; 2007; 77(1-2):64-8. PubMed ID: 17295824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast.
    Barnes NL; Dimopoulos N; Williams KE; Howe M; Bundred NJ
    Eur J Surg Oncol; 2014 Mar; 40(3):249-54. PubMed ID: 24433818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local tumor recurrence following breast-conservation therapy: correlation of histopathologic findings with detection method and mammographic findings.
    Giess CS; Keating DM; Osborne MP; Rosenblatt R
    Radiology; 1999 Sep; 212(3):829-35. PubMed ID: 10478253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative histological diagnosis of breast cancer.
    Serpell JW; Johnson WR
    Aust N Z J Surg; 1997 Jun; 67(6):325-9. PubMed ID: 9193264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.
    Kuhl CK; Strobel K; Bieling H; Wardelmann E; Kuhn W; Maass N; Schrading S
    Radiology; 2017 Sep; 284(3):645-655. PubMed ID: 28445683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overdiagnosis and overtreatment of breast cancer: rates of ductal carcinoma in situ: a US perspective.
    Kumar AS; Bhatia V; Henderson IC
    Breast Cancer Res; 2005; 7(6):271-5. PubMed ID: 16457703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast conservation surgery without pre-operative mammography--a definite feasibility.
    Nadkarni MS; Gupta PB; Parmar VV; Badwe RA
    Breast; 2006 Oct; 15(5):595-600. PubMed ID: 16517163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palpable ductal carcinoma in situ: analysis of radiological and histological features of a large series with 5-year follow-up.
    Sundara Rajan S; Verma R; Shaaban AM; Sharma N; Dall B; Lansdown M
    Clin Breast Cancer; 2013 Dec; 13(6):486-91. PubMed ID: 24267733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of mammographic screening on the surgical management of breast cancer.
    James TA; Wade JE; Sprague BL
    J Surg Oncol; 2016 Apr; 113(5):496-500. PubMed ID: 26799535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions?
    Hoorntje LE; Peeters PH; Mali WP; Borel Rinkes IH
    Breast Cancer Res Treat; 2004 Jul; 86(2):165-70. PubMed ID: 15319568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core imprint cytology of screen-detected breast lesions is predictive of the histologic results.
    Farshid G; Pieterse S
    Cancer; 2006 Jun; 108(3):150-6. PubMed ID: 16634070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of breast cancer through population-based mammographic screening in Asian women: a comparison study between screen-detected and symptomatic breast cancers.
    Chuwa EW; Yeo AW; Koong HN; Wong CY; Yong WS; Tan PH; Ho JT; Wong JS; Ho GH
    Breast J; 2009; 15(2):133-9. PubMed ID: 19292798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological classification of ductal carcinoma in situ of the breast correlates with surgical treatment and may be predicted by mammography.
    Ponzone R; Dominguez A; Marra V; Pisacane A; Maggiorotto F; Jacomuzzi ME; Magistris A; Biglia N; Sismondi P
    Breast; 2007 Oct; 16(5):495-502. PubMed ID: 17507226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.